The Asian Age - - Science+ Health -

Wash­ing­ton, Sept. 15: Ac­cord­ing to a study, testos­terone re­place­ment ther­apy may slow the pro­gres­sion of chronic ob­struc­tive pul­monary dis­ease ( COPD).

COPD is a chronic in­flam­ma­tory lung dis­ease that causes ob­structed air­flow from the lungs. It is pre­dicted by the World Health Or­gan­i­sa­tion to be the third- lead­ing cause of ill­ness and death in­ter­na­tion­ally by 2030.

Low testos­terone is com­mon in men with COPD and may worsen their con­di­tion. Men with COPD have short­ness of breath and of­ten take steroid- based med­i­ca­tions for an ex­tended time, both of which in­crease their risk of low testos­terone.

“Pre­vi­ous stud­ies have sug­gested that testos­terone re­place­ment ther­apy may have a pos­i­tive ef­fect on lung func­tion in men with COPD,” said Jac­ques Bail­largeon of The Univer­sity of Texas Med­i­cal Branch at Galve­ston.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.